RespireRx Pharmaceuticals Inc (RSPI)

[gfp927z]

Dew, This disclosure was actually via an 8-K filing, as opposed to a regular press release, but either way, I guess the ongoing Cortex "malaise" continues..

Things can change rapidly with these stocks however. I remember being thoroughly disillusioned with Biomarin after their disastrous Orapred acquisition and the clinical failure of their Neutralase program. The CEO was fired, and the stock collapsed to around $4. But lo and behold, they gradually built a new team, got an approval, and recovered to the current $18-19 range. Epix was another company that was seemingly being lowered into its grave, only to turn things around via a desperate acquisition and subsequent big pharma deal. So what looks awful now can sometimes be turned around. Then again, what looks awful can actually be awful, and stay awful. Sometimes it just comes down to some good or bad luck at a critical time. The FDA suddenly getting irrationally hypercritical of ADHD drugs at the exact time that Cortex discovers potentially the best ADHD drug ever, that would qualify as some of the worst luck ever. The fat lady hasn't finished singing yet though.